
Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial
2024; Elsevier BV; Volume: 120; Issue: 3 Linguagem: Inglês
10.1016/j.ajcnut.2024.06.016
ISSN1938-3207
AutoresGilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Thiago Santiago Ferreira, Castilho Vitor Quirino dos Santos, Ana Paula Figueiredo Guimaraes Almeida, Leonardo Cançado Monteiro Savassi, Adhemar Dias de Figueiredo Neto, Luíza Lanna França Reis, Vitoria Helena de Souza Campos, Carina Bitarães, Eduardo Diniz Callegari, Maria Izabel Campos Simplicio, Luciene Barra Ribeiro, Rosemary Oliveira, Ofir Harari, Jamie I. Forrest, Prince Kumar Lat, Louis Dron, Kristian Thorlund, Edward J. Mills,
Tópico(s)Intensive Care Unit Cognitive Disorders
ResumoAlgae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clinical consequences to COVID-19 infections.
Referência(s)